{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:38:44Z","timestamp":1789958324377,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Yanfeu Yu","award":["the Scientific Research Seed Fund of Peking University First Hospital 2020SF36"],"award-info":[{"award-number":["the Scientific Research Seed Fund of Peking University First Hospital 2020SF36"]}]},{"name":"Shiming He","award":["National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital) 2024IR30"],"award-info":[{"award-number":["National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital) 2024IR30"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05941-6","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:56:36Z","timestamp":1758520596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fumarate hydratase-deficient renal cell carcinoma: high intratumoral and peritumoral CD4-positive T cell infiltration density and high PD-L1 expression"],"prefix":"10.1007","volume":"43","author":[{"given":"Yanfei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mancheng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"5941_CR1","doi-asserted-by":"publisher","first-page":"e58470","DOI":"10.7759\/cureus.58470","volume":"16","author":"PR Goswami","year":"2024","unstructured":"Goswami PR, Singh G, Patel T et al (2024) The WHO 2022 classification of renal neoplasms (5th edition): salient updates. Cureus 16:e58470. https:\/\/doi.org\/10.7759\/cureus.58470","journal-title":"Cureus"},{"key":"5941_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaad.2017.01.023","volume":"77","author":"VM Patel","year":"2017","unstructured":"Patel VM, Handler MZ, Schwartz RA et al (2017) Hereditary leiomyomatosis and renal cell cancer syndrome: an update and review. J Am Acad Dermatol 77:149\u2013158. https:\/\/doi.org\/10.1016\/j.jaad.2017.01.023","journal-title":"J Am Acad Dermatol"},{"key":"5941_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.18926\/amo\/62237","volume":"75","author":"T Sekito","year":"2021","unstructured":"Sekito T, Takamoto A, Kobayashi Y et al (2021) A case of metastatic fumarate Hydratase-Deficient-like renal cell carcinoma successfully managed by ipilimumab plus nivolumab. Acta Med Okayama 75:397\u2013402. https:\/\/doi.org\/10.18926\/amo\/62237","journal-title":"Acta Med Okayama"},{"key":"5941_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejca.2021.04.009","volume":"151","author":"L Carril-Ajuria","year":"2021","unstructured":"Carril-Ajuria L, Colomba E, Cerbone L et al (2021) Response to systemic therapy in fumarate hydratase-deficient renal cell carcinoma. Eur J Cancer 151:106\u2013114. https:\/\/doi.org\/10.1016\/j.ejca.2021.04.009","journal-title":"Eur J Cancer"},{"key":"5941_CR5","first-page":"4554","volume":"62","author":"M Kiuru","year":"2002","unstructured":"Kiuru M, Lehtonen R, Arola J et al (2002) Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res 62:4554\u20134557","journal-title":"Cancer Res"},{"key":"5941_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM et al (2022) The 2022 world health organization classification of tumours of the urinary system and male genital organs-Part A: renal, penile, and testicular tumours. Eur Urol 82:458\u2013468. https:\/\/doi.org\/10.1016\/j.eururo.2022.06.016","journal-title":"Eur Urol"},{"key":"5941_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2174\/1566524043359638","volume":"4","author":"M Kiuru","year":"2004","unstructured":"Kiuru M, Launonen V (2004) Hereditary leiomyomatosis and renal cell cancer (HLRCC). Curr Mol Med 4:869\u2013875. https:\/\/doi.org\/10.2174\/1566524043359638","journal-title":"Curr Mol Med"},{"key":"5941_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151599","volume":"49","author":"N Kuroda","year":"2020","unstructured":"Kuroda N, Tsutsui M, Iguchi M et al (2020) Fumarate hydratase-deficient renal cell carcinoma: a clinicopathological study of seven cases including hereditary and sporadic forms. Ann Diagn Pathol 49:151599. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151599","journal-title":"Ann Diagn Pathol"},{"key":"5941_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","volume":"10","author":"HJ Lehtonen","year":"2011","unstructured":"Lehtonen HJ (2011) Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer 10:397\u2013411. https:\/\/doi.org\/10.1007\/s10689-011-9428-z","journal-title":"Fam Cancer"},{"key":"5941_CR10","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","volume":"23","author":"LJ Castro-Vega","year":"2014","unstructured":"Castro-Vega LJ, Buffet A, De Cubas AA et al (2014) Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet 23:2440\u20132446. https:\/\/doi.org\/10.1093\/hmg\/ddt639","journal-title":"Hum Mol Genet"},{"key":"5941_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/pas.0000000000001945","volume":"47","author":"TL Fuchs","year":"2023","unstructured":"Fuchs TL, Luxford C, Clarkson A et al (2023) A clinicopathologic and molecular analysis of fumarate Hydratase-deficient pheochromocytoma and paraganglioma. Am J Surg Pathol 47:25\u201336. https:\/\/doi.org\/10.1097\/pas.0000000000001945","journal-title":"Am J Surg Pathol"},{"key":"5941_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","volume":"189","author":"B Shuch","year":"2013","unstructured":"Shuch B, Ricketts CJ, Vocke CD et al (2013) Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol 189:430\u2013435. https:\/\/doi.org\/10.1016\/j.juro.2012.07.139","journal-title":"J Urol"},{"key":"5941_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/10668969211026241","volume":"30","author":"N Wyvekens","year":"2022","unstructured":"Wyvekens N, Anderson WJ, Kim YX et al (2022) Low-grade fumarate hydratase-deficient renal cell carcinoma in a 30-year-old female. Int J Surg Pathol 30:184\u2013189. https:\/\/doi.org\/10.1177\/10668969211026241","journal-title":"Int J Surg Pathol"},{"key":"5941_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/pap.0000000000000321","volume":"28","author":"A Hamza","year":"2021","unstructured":"Hamza A, Sirohi D, Smith SC et al (2021) Low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma: an update on biologic potential, morphologic spectrum, and differential diagnosis with other low-grade oncocytic tumors. Adv Anat Pathol 28:396\u2013407. https:\/\/doi.org\/10.1097\/pap.0000000000000321","journal-title":"Adv Anat Pathol"},{"key":"5941_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/his.13183","volume":"71","author":"SC Smith","year":"2017","unstructured":"Smith SC, Sirohi D, Ohe C et al (2017) A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma. Histopathology 71:42\u201352. https:\/\/doi.org\/10.1111\/his.13183","journal-title":"Histopathology"},{"key":"5941_CR16","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2023-0330-OA","author":"X Yang","year":"2024","unstructured":"Yang X, Liu Y, Wang H et al (2024) Fumarate hydratase-deficient renal cell carcinoma with predominant tubulocystic features mimics tubulocystic renal cell carcinoma. Arch Pathol Lab Med. https:\/\/doi.org\/10.5858\/arpa.2023-0330-OA","journal-title":"Arch Pathol Lab Med"},{"key":"5941_CR17","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","volume":"12","author":"NA Alam","year":"2003","unstructured":"Alam NA, Rowan AJ, Wortham NC et al (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12:1241\u20131252. https:\/\/doi.org\/10.1093\/hmg\/ddg148","journal-title":"Hum Mol Genet"},{"key":"5941_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s1525-1578(10)60574-0","volume":"7","author":"NA Alam","year":"2005","unstructured":"Alam NA, Olpin S, Rowan A et al (2005) Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn 7:437\u2013443. https:\/\/doi.org\/10.1016\/s1525-1578(10)60574-0","journal-title":"J Mol Diagn"},{"key":"5941_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/path.1686","volume":"205","author":"P Pollard","year":"2005","unstructured":"Pollard P, Wortham N, Barclay E et al (2005) Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome. J Pathol 205:41\u201349. https:\/\/doi.org\/10.1002\/path.1686","journal-title":"J Pathol"},{"issue":"6","key":"5941_CR20","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/ijc.22819","volume":"121","author":"HJ Lehtonen","year":"2007","unstructured":"Lehtonen HJ, Makinen MJ, Kiuru M et al (2007) Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability. Int J Cancer 121(6):1386\u20131389. https:\/\/doi.org\/10.1002\/ijc.22819","journal-title":"Int J Cancer"},{"key":"5941_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.humpath.2022.12.013","volume":"134","author":"R Mannan","year":"2023","unstructured":"Mannan R, Wang X, Bawa PS et al (2023) Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma. Hum Pathol 134:102\u2013113. https:\/\/doi.org\/10.1016\/j.humpath.2022.12.013","journal-title":"Hum Pathol"},{"key":"5941_CR22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/pas.0000000000000163","volume":"38","author":"Y-B Chen","year":"2014","unstructured":"Chen Y-B, Brannon AR, Toubaji A et al (2014) Hereditary leiomyomatosis and renal cell carcinoma syndrome\u2013associated renal cancer. Am J Surg Pathol 38:627\u2013637. https:\/\/doi.org\/10.1097\/pas.0000000000000163","journal-title":"Am J Surg Pathol"},{"key":"5941_CR23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/pas.0000000000000617","volume":"40","author":"K Trpkov","year":"2016","unstructured":"Trpkov K, Hes O, Agaimy A et al (2016) Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome. Am J Surg Pathol 40:865\u2013875. https:\/\/doi.org\/10.1097\/pas.0000000000000617","journal-title":"Am J Surg Pathol"},{"key":"5941_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2022.152007","volume":"60","author":"Y Liu","year":"2022","unstructured":"Liu Y, Dong Y, Gu Y et al (2022) GATA3 aids in distinguishing fumarate hydratase-deficient renal cell carcinoma from papillary renal cell carcinoma. Ann Diagn Pathol 60:152007. https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152007","journal-title":"Ann Diagn Pathol"},{"key":"5941_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/pas.0000000000001372","volume":"44","author":"HD Lau","year":"2020","unstructured":"Lau HD, Chan E, Fan AC et al (2020) A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients. Am J Surg Pathol 44:98\u2013110. https:\/\/doi.org\/10.1097\/pas.0000000000001372","journal-title":"Am J Surg Pathol"},{"key":"5941_CR26","doi-asserted-by":"publisher","unstructured":"Grubb RL 3rd, Franks ME, Toro J et al (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177:2074\u20132079 discussion 2079-80. https:\/\/doi.org\/10.1016\/j.juro.2007.01.155","DOI":"10.1016\/j.juro.2007.01.155"},{"key":"5941_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ucl.2012.01.006","volume":"39","author":"B Shuch","year":"2012","unstructured":"Shuch B, Singer EA, Bratslavsky G (2012) The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors. Urol Clin North Am 39:133\u2013148. https:\/\/doi.org\/10.1016\/j.ucl.2012.01.006","journal-title":"Urol Clin North Am"},{"key":"5941_CR28","doi-asserted-by":"publisher","first-page":"1373020","DOI":"10.3389\/fphar.2024.1373020","volume":"15","author":"X Bai","year":"2024","unstructured":"Bai X, Xiang D, Huang M et al (2024) Case report: successful response to bevacizumab combined with erlotinib for a novel FH gene mutation hereditary leiomyoma and renal cell carcinoma. Front Pharmacol 15:1373020. https:\/\/doi.org\/10.3389\/fphar.2024.1373020","journal-title":"Front Pharmacol"},{"key":"5941_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12894-019-0484-2","volume":"19","author":"I Park","year":"2019","unstructured":"Park I, Shim YS, Go H et al (2019) Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures. BMC Urol 19:51. https:\/\/doi.org\/10.1186\/s12894-019-0484-2","journal-title":"BMC Urol"},{"key":"5941_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/jcp-2022-208589","volume":"77","author":"D Kiyozawa","year":"2024","unstructured":"Kiyozawa D, Kohashi K, Takamatsu D et al (2024) Comparative analyses of tumour immune microenvironment between collecting duct carcinoma and fumarate hydratase-deficient renal cell carcinoma. J Clin Pathol 77:105\u2013110. https:\/\/doi.org\/10.1136\/jcp-2022-208589","journal-title":"J Clin Pathol"},{"key":"5941_CR31","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1158\/1078-0432.Ccr-23-2760","volume":"30","author":"J Chen","year":"2024","unstructured":"Chen J, Hu X, Zhao J et al (2024) Memory\/active T-cell activation is associated with immunotherapeutic response in fumarate hydratase\u2013deficient renal cell carcinoma. Clin Cancer Res 30:2571\u20132581. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-2760","journal-title":"Clin Cancer Res"},{"key":"5941_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14562-6","author":"J Bai","year":"2025","unstructured":"Bai J, Huang J, Ye Y et al (2025) Clinicopathologic and prognosis of 30 patients with FH-deficient renal cell carcinoma: a single-center retrospective study. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-025-14562-6","journal-title":"BMC Cancer"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05941-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05941-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05941-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:03:11Z","timestamp":1767996191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05941-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5941"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05941-6","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Peking University First Hospital (Approval No. 2020-Yan-428).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study, or from their legal guardian in the case of minors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"567"}}